68 related articles for article (PubMed ID: 12527529)
21. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
22. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
[TBL] [Abstract][Full Text] [Related]
23. The association between seated immobility and local lower-limb venous coagulability in healthy adult volunteers: a simulation of prolonged travel immobility.
Ansari MT; Mahmood MT; Karlberg JP
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):335-41. PubMed ID: 16788308
[TBL] [Abstract][Full Text] [Related]
24. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
25. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
26. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
Li F; Zhang G; Zhao W
Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
[TBL] [Abstract][Full Text] [Related]
27. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
28. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
Bruni F; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Cercigani M; Leo A; Auteri A; Puccetti L
Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
Apetrei E; Ciobanu-Jurcuţ R; Rugină M; Gavrilă A; Uscătescu V
Rom J Intern Med; 2004; 42(1):95-102. PubMed ID: 15529598
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
[TBL] [Abstract][Full Text] [Related]
31. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
[TBL] [Abstract][Full Text] [Related]
33. [Study on endothelial dysfunction and platelet activation in elderly hypertensive patients complicated with cerebral infarction].
Li YN; Yuan H; Zhang MX
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):143-5. PubMed ID: 12536649
[TBL] [Abstract][Full Text] [Related]
34. [Disorders of anticoagulation and fibrinolysis in monoclonal gammopathies--another mechanism of paraprotein interference with hemostasis].
Spicka I; Cieslar P; Hrkal Z; Fortová H; Simonianová E; Zounar R; Klener P
Sb Lek; 1996; 97(3):369-75. PubMed ID: 9235617
[TBL] [Abstract][Full Text] [Related]
35. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
36. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
37. [Activation of fibrynolysis in children with chronic B or C hepatitis].
Michalska K; Szaflarska-Popławska A; Dymek G; Kotschy M
Pol Merkur Lekarski; 2004 Oct; 17(100):316-20. PubMed ID: 15690691
[TBL] [Abstract][Full Text] [Related]
38. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
[TBL] [Abstract][Full Text] [Related]
39. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
40. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
